Zacks Research Expects Weaker Earnings for Merck & Co., Inc.
Merck & Co., Inc. (NYSE:MRK – Free Report) – Equities researchers at Zacks Research dropped their Q1 2025 earnings estimates for Merck & Co., Inc. in a note issued to investors on Wednesday, February 26th. Zacks Research analyst S. Ganoria now anticipates that the company will earn $2.17 per share for the quarter, down from […]
